Do you want to read an article? Please log in or register.
Proton therapy for head and neck cancer: expanding the therapeutic window
Head and Neck Cancer
Related content
RECOMMENDED
Head and Neck Cancer
Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study
Eur J Cancer.
Simon C, Caballero C, Gregoire V, Thurnher D, Koivunen P, Ceruse P, Spriano G, Nicolai P, Licitra L, Machiels JP, Hamoir M, Andry G, Mehanna H, Hunter KD, Dietz A, René Leemans C
doi: 10.1016/j.ejca.2018.07.140.
Head and Neck Cancer
Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base
Cancer.
Zumsteg ZS, Luu M, Yoshida EJ, Kim S, Tighiouart M, David JM, Shiao SL, Mita AC, Scher KS, Sherman EJ, Lee NY, Ho AS
doi: 10.1002/cncr.30933.
Head and Neck Cancer
Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles
J Oncol Pharm Pract.
Vucur C, Wirtz DA, Weinhold L, Zipfel M, Schmid M, Schmidt-Wolf IG, Jaehde U
doi: 10.1177/1078155220962178.
Head and Neck Cancer
Targeted Therapy of Head and Neck Cancer
Oncol Res Treat.
Rieke DT, Klinghammer K, Keilholz U
doi: 10.1159/000452432
RECOMMENDED
Head and Neck Cancer
Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy
★ 2
Recommended by
Prof. Dr Stephan Bodis, Faculty Member
doi: 10.1016/j.ejca.2020.02.047.
Head and Neck Cancer
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)
Front Oncol.
Dulguerov P, Broglie MA, Henke G, Siano M, Putora PM, Simon C, Zwahlen D, Huber GF, Ballerini G, Beffa L, Giger R, Rothschild S, Negri SV, Elicin O
doi: 10.3389/fonc.2019.01125.
Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection
Clin Cancer Res.
Niehr F, Eder T, Pilz T, Konschak R, Treue D, Klauschen F, Bockmayr M, Türkmen S, Jöhrens K, Budach V, Tinhofer I
doi: 10.1158/
Head and Neck Cancer
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw.
Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD
doi: 10.6004/jnccn.2020.0031.
Head and Neck CancerRadio-Oncology
The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)
Radiother Oncol.
Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C, Verheij M, Remeijer P, Sonke JJ, van den Brekel M, Al-Mamgani A
doi: 10.1016/j.radonc.2018.06.032.